Analysis reveals that Erbb3 and Igf1 signaling regulate uterine gland branching, impacting implantation success.
Uterine gland branching is a prerequisite for glandular secretion, such as leukemia inhibitory factor (LIF), thereby establishing uterine receptivity to support embryo implantation. Previous studies have demonstrated that epidermal growth factors and their receptors play key roles in mouse pregnancy. Specifically, Uterine deletion of Erbb3, a member of the ERBB receptor family, using Pgr-Cre (Erbb3d/d or Erbb3f/f PgrCre/+) results in approximately 70% of plug-positive females failing to deliver any live progeny, whereas uterine epithelial deletion of Erbb3 using Ltf-Cre (Erbb3epi/epi or Erbb3f/f LtfCre/+) show normal fertility. Here, we identify stromal Erbb3 as a key regulator of uterine gland branching and embryo implantation. Tridimensional visualization reveals that Erbb3d/d uterine glands lack normal branching, accompanied by reduced in Lif mRNA expression. However, LIF supplementation only partially rescues implantation. Transcriptomic profiling of day 3 stromal cells identified Igf1 as one of the downregulated growth factors in Erbb3d/d females, implicating its involvement in gland development. Moreover, uterine deletion of Igf1r (Igf1rf/f PgrCre/+) leads to a reduced gland branching phenotype similar to that observed in Erbb3d/d uteri. Together, these results uncover a critical Erbb3-Igf1-Igf1r signaling axis mediating stromal-to-epithelial communication that drives uterine gland branching and ensures successful implantation.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: